Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

December 02, 2019

Takeda Pharmaceuticals U.S.A., Inc. v. Mylan Pharmaceuticals Inc.

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. September 27, 2023

    Mylan Dodges Contract Breach Claim In Takeda IP Fight

    A Delaware federal judge on Wednesday agreed to hand Mylan a win on a breach of contract claim from Takeda Pharmaceuticals USA Inc. over its gout drug Colcrys, agreeing with Mylan's interpretation of an earlier settlement agreement.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login